“Reactive Angioendotheliomatosis with Atypical Features Following Immune Checkpoint Inhibitor Therapy: A Diagnostic Challenge”, IJMHR , vol. 14, no. 2, pp. 1–6, Oct. 2026, doi: 10.71393/w7hjee54.